Expected earnings - Telomir Pharmaceuticals Inc.
Source: US Earnings Reports
Telomir Pharmaceuticals Inc. (TELO) is expected to report $-0.07 for Q4 2025
Telomir Pharmaceuticals Inc.
NASDAQ: TELO
TELO Trading
-0.39% G/L:
$1.275 Last:
27,291 Volume:
$1.27 Open:
TELO Latest News
April 03, 2026 10:12:42 am
Head to Head Review: Telomir Pharmaceuticals (NASDAQ:TELO) and Jaguar Animal Health (NASDAQ:JAGX)
March 31, 2026 10:15:00 am
InvestorNewsBreaks - Telomir Pharmaceuticals (NASDAQ: TELO) Submits IND for TNBC Candidate Telomir-1
TELO Stock Data
$40,225,736
20,889,878
N/A
14
N/A
Biotechnology & Life Sciences
Healthcare
US
Miami
